Arrakis Therapeutics Announces $75 Million Series B Financing To Advance a New Class of Small-Molecule Medicines Targeting RNAView More
insitro Strikes AI Drug Discovery Deal with Gilead for NASH, with up to $50 million in Near-Term Payments and $1 Billion in Deal ValueView More
Alnylam and Regeneron Sign Potential $1 Billion RNAi PactView More
Goodwin Highly Ranked in PitchBook’s 2018 US Private Equity Lending League TablesView More
Sorry we did not find any results.